Alan S Gamis MD MPH

PubMed

• 1 citations
  Epigenomic diagnosis and prognosis of Acute Myeloid Leukemia.
  Francisco Marchi, Vivek M Shastri, Richard J Marrero, Nam H K Nguyen, Antonella Öttl
  Nature Communications. 2025-07-29
• Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology Group.
  Benjamin J Huang, Lauren K Meyer, Todd A Alonzo, Yi-Cheng Wang, Adam J Lamble
  Journal of Clinical Oncology. 2025-06-10
• Cytarabine Pharmacogenomics and Outcomes Among Children and Young Adults With Acute Myeloid Leukemia.
  Richard J Marrero, Vivek M Shastri, Deedra Nicolet, Krzysztof Mrózek, Christopher J Walker
  JAMA Network Open. 2025-06-02

Abstracts/Posters

• Sorafenib in Combination with Standard Chemotherapy for Children with High Allelic Ratio FLT3/ITD+ AML Improves Event-Free Survival and Reduces Relapse Risk: A Report ...
  Alan S Gamis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Prognostic Significance of FOXO3 in Pediatric Acute Myeloid Leukemia (AML) Patients Treated with Bortezomib Addition to Standard Therapy: Results from a ChildrenÍs Onc...
  Alan S Gamis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Response to Sorafenib in FLT3/ITD AML Is Depedent on Co-Occurring Mutational Profile
  Alan S Gamis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Structural Variants Involving MLLT10/AF10 Are Associated with Adverse Outcome in AML Regardless of the Partner Gene _ a COG/Tpaml Study
  Alan S Gamis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Occurrence and Resolution of Anthracycline Cardiotoxicity and Impact on Treatment Outcomes Among Children Treated on the AAML1031 Clinical Trial: A Report from the Chi...
  Alan S Gamis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• CD117 Expression Is Associated with Cytogenetic and Molecular Profiles and Outcome in Pediatric Acute Myeloid Leukemia
  Alan S Gamis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Somatic Bzip Mutations of CEBPA Are Associated with Favorable Outcome Regardless of Presence As Single Vs. Double Mutation
  Alan S Gamis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• High-Dose Cytarabine Is Indispensable for the Survival of Children with Myeloid Leukemia of Down Syndrome Despite Negative Minimal Residual Disease Post-Induction
  Alan S Gamis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Area-Based Socioeconomic Disparities in Survival of Children with Newly Diagnosed Acute Myeloid Leukemia: A Report from the ChildrenÍs Oncology Group
  Alan S Gamis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Long Non-Coding RNAs (lncRNAs) Are Highly Associated with Disease Characteristics and Outcome in Pediatric Acute Myeloid Leukemia _ a COG and Tpaml Study
  Alan S Gamis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• Enhancement of Eligibility Guidelines for Gemtuzumab Ozogamicin Therapy for Childhood Acute Myeloid Leukemia: A Report from Children's Oncology Group Protocol AAML0531 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018